imipramine has been researched along with Tremor in 33 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment of dysthymia (DSM-III-R)." | 9.08 | Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. ( Amrein, R; Stabl, M; Versiani, M, 1997) |
| "Assessment of an elderly depressed patient with an imipramine-induced tremor led to the conclusions that imipramine tremor (1) can be severe and incapacitating, (2) is most pronounced early in the treatment, (3) does not seem to be dose-related, and (4) is readily reversible with a beta-adrenergic blocking agent." | 7.66 | Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. ( Greden, JF; Kronfol, Z; Zis, AP, 1983) |
| "Imipramine treatment further decreased harmaline-induced 5HT turnover in the brain stem." | 5.33 | Exacerbation of harmaline-induced tremor by imipramine. ( Al Deeb, S; Al Moutaery, K; Arshaduddin, M; Kadasah, S; Tariq, M, 2005) |
| "An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment of dysthymia (DSM-III-R)." | 5.08 | Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. ( Amrein, R; Stabl, M; Versiani, M, 1997) |
| "The anticholinergic effect of atropine, imipramine, clomipramine and metapramine was evaluated on oxotremorine induced trembling in the mouse as well as on contractions of the isolated guinea pig ileum induced by electrical stimulation of the mesenteric plexus." | 3.67 | [Evaluation of the central anticholinergic activity of antidepressants. Comparison of two experimental methods]. ( Billa, JP; Dufour, P; Fabre, J; Roquebert, J, 1989) |
| "Assessment of an elderly depressed patient with an imipramine-induced tremor led to the conclusions that imipramine tremor (1) can be severe and incapacitating, (2) is most pronounced early in the treatment, (3) does not seem to be dose-related, and (4) is readily reversible with a beta-adrenergic blocking agent." | 3.66 | Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. ( Greden, JF; Kronfol, Z; Zis, AP, 1983) |
| " Side effect information was collected at each visit." | 2.65 | An overview of side effects and long-term experience with nomifensine from United States clinical trials. ( Hardiman, S; Nash, RJ; Yakabow, AL, 1984) |
| "On treatment with imipramine, wild-type mice became sedated and produced imipramine N-oxide in the brain and other tissues." | 1.35 | Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine. ( Chandan, P; Hernandez, D; Janmohamed, A; Omar, BA; Phillips, IR; Shephard, EA, 2009) |
| " The effect of chronic ACTH treatment on 5-HT(2) receptor and 5-HT(2A)-receptor mRNA levels was not altered by the chronic administration of imipramine." | 1.35 | Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex. ( Akiyama, K; Fujitani, Y; Gomita, Y; Kanzaki, H; Kawasaki, H; Kimoto, S; Kitagawa, K; Kitamura, Y; Ouchida, M; Sendo, T; Shibata, K; Shimizu, K, 2008) |
| "Imipramine treatment further decreased harmaline-induced 5HT turnover in the brain stem." | 1.33 | Exacerbation of harmaline-induced tremor by imipramine. ( Al Deeb, S; Al Moutaery, K; Arshaduddin, M; Kadasah, S; Tariq, M, 2005) |
| "Imipramine methiodide is a quaternary derivative of imipramine which does not cross the blood-brain barrier easily." | 1.27 | Comparison of imipramine-imipraminium in mice. To elucidate central or peripheral origin of effects of imipramine. ( Frances, H; Simon, P, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (87.88) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernandez, D | 1 |
| Janmohamed, A | 1 |
| Chandan, P | 1 |
| Omar, BA | 1 |
| Phillips, IR | 1 |
| Shephard, EA | 1 |
| ENGLISH, HL | 1 |
| KANE, FJ | 1 |
| TAYLOR, TW | 1 |
| THEOBALD, W | 1 |
| BUECH, O | 1 |
| KUNZ, HA | 1 |
| MORPURGO, C | 1 |
| STENGER, EG | 1 |
| WILHELMI, G | 1 |
| Arshaduddin, M | 1 |
| Kadasah, S | 1 |
| Al Deeb, S | 1 |
| Al Moutaery, K | 1 |
| Tariq, M | 1 |
| Kitamura, Y | 1 |
| Shibata, K | 1 |
| Akiyama, K | 1 |
| Kimoto, S | 1 |
| Fujitani, Y | 1 |
| Kitagawa, K | 1 |
| Kanzaki, H | 1 |
| Ouchida, M | 1 |
| Shimizu, K | 1 |
| Kawasaki, H | 1 |
| Sendo, T | 1 |
| Gomita, Y | 1 |
| Yakabow, AL | 1 |
| Hardiman, S | 1 |
| Nash, RJ | 1 |
| Kronfol, Z | 1 |
| Greden, JF | 1 |
| Zis, AP | 1 |
| Versiani, M | 1 |
| Amrein, R | 1 |
| Stabl, M | 1 |
| Rehavi, M | 2 |
| Maayani, S | 2 |
| Goldstein, L | 1 |
| Assael, M | 1 |
| Sokolovsky, M | 2 |
| Silvestrini, B | 1 |
| Lisciani, R | 1 |
| Angst, J | 2 |
| Woggon, B | 2 |
| Schoepf, J | 1 |
| Cendrowski, W | 1 |
| Karniol, IG | 1 |
| Dalton, J | 1 |
| Lader, M | 1 |
| Dekret, JJ | 1 |
| Maany, I | 1 |
| Ramsey, TA | 1 |
| Mendels, J | 1 |
| Dittmer, TL | 1 |
| Heinrich, K | 1 |
| Hippius, H | 1 |
| Seibel, I | 1 |
| Dufour, P | 1 |
| Billa, JP | 1 |
| Fabre, J | 1 |
| Roquebert, J | 1 |
| Levine, S | 1 |
| Deo, R | 1 |
| Mahadevan, K | 1 |
| Frances, H | 2 |
| Simon, P | 1 |
| Vaupel, DB | 1 |
| Martin, WR | 1 |
| Zelikman, TIa | 1 |
| Shekhtman, ML | 1 |
| Srimal, RC | 1 |
| Singh, HK | 1 |
| Dhawan, BN | 1 |
| Schulterbrandt, JG | 1 |
| Raskin, A | 1 |
| Reatig, N | 1 |
| Eggermont, E | 1 |
| Raveschot, J | 1 |
| Deneve, V | 1 |
| Casteels-van Daele, M | 1 |
| Sofia, RD | 1 |
| Kubena, RK | 1 |
| Barry, H | 1 |
| Saraf, KR | 1 |
| Klein, DF | 1 |
| Gittelman-Klein, R | 1 |
| Groff, S | 1 |
| Jacob, J | 1 |
| Nikki, P | 1 |
| Lippmann, W | 1 |
| Sjöqvist, F | 1 |
| Hammer, W | 1 |
| Schumacher, H | 1 |
| Gillette, J | 1 |
| Achari, G | 1 |
| Sinha, SP | 1 |
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
7 trials available for imipramine and Tremor
| Article | Year |
|---|---|
An overview of side effects and long-term experience with nomifensine from United States clinical trials.
Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Depressive Disorder; Dizziness; Headache; | 1984 |
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Consti | 1997 |
The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Synergis | 1977 |
[Clinical trial of lofepramine versus imipramine].
Topics: Acetophenones; Adult; Clinical Trials as Topic; Constipation; Depression; Dibenzazepines; Drug Evalu | 1975 |
A comparative trial of a new antidepressant, fluoxetine.
Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female | 1987 |
True and apparent side effects in a controlled trial of chlorpromazine and imipramine in depression.
Topics: Adult; Agranulocytosis; Chlorpromazine; Clinical Trials as Topic; Depression; Dermatitis; Edema; Eva | 1974 |
Imipramine side effects in children.
Topics: Adolescent; Anorexia Nervosa; Blood Pressure; Child; Constipation; Death, Sudden; Depression, Chemic | 1974 |
26 other studies available for imipramine and Tremor
| Article | Year |
|---|---|
Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Cells, Cultured; Chromosomes; Embryonic | 2009 |
An alarming side-effect of tofranil.
Topics: Drug-Related Side Effects and Adverse Reactions; Equipment Failure; Humans; Iatrogenic Disease; Imip | 1959 |
An unusual reaction to combined imipramine-thorazine therapy.
Topics: Chlorpromazine; Imipramine; Reflex; Spasm; Speech Disorders; Tremor | 1963 |
[COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS WITH TOFRANIL, PERTOFRAN AND INSIDON].
Topics: Acetylcholine; Amphetamine; Amphetamines; Anesthetics; Animals; Antidepressive Agents; Catatonia; Ca | 1964 |
Exacerbation of harmaline-induced tremor by imipramine.
Topics: Animals; Drug Synergism; Harmaline; Imipramine; Male; Rats; Rats, Sprague-Dawley; Tremor | 2005 |
Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Binding Sites; | 2008 |
Imipramine-induced tremor: effects of a beta-adrenergic blocking agent.
Topics: Depressive Disorder; Humans; Imipramine; Male; Middle Aged; Propranolol; Tremor | 1983 |
Antimuscarinic properties of antidepressants: dibenzepin (Noveril).
Topics: Animals; Body Temperature; Dibenzazepines; Guinea Pigs; Imipramine; In Vitro Techniques; Male; Mice; | 1977 |
Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Clonidine; Female; Fenclonine; Imipramine; Male; Mice; Mice, | 1976 |
[Attempts at pharmacological and surgical treatment of intentional and postural tremor in patients with disseminated sclerosis (authors transl)].
Topics: Adult; Amitriptyline; Evaluation Studies as Topic; Female; Humans; Imipramine; Male; Middle Aged; Mu | 1976 |
Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects.
Topics: Acoustic Stimulation; Adult; Blood Pressure; Diazepam; Dose-Response Relationship, Drug; Evoked Pote | 1976 |
Tricyclic antidepressants as antimuscarinic drugs: in vivo and in vitro studies.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Body Temperature; Brain; Cholinesterase In | 1977 |
A case of oral dyskinesia associated with imipramine treatment.
Topics: Dyskinesia, Drug-Induced; Humans; Imipramine; Male; Middle Aged; Mouth; Tremor | 1977 |
[Evaluation of the central anticholinergic activity of antidepressants. Comparison of two experimental methods].
Topics: Animals; Antidepressive Agents, Tricyclic; Atropine; Clomipramine; Dibenzazepines; Female; Guinea Pi | 1989 |
Comparison of imipramine-imipraminium in mice. To elucidate central or peripheral origin of effects of imipramine.
Topics: Animals; Apomorphine; Body Temperature; Drug Synergism; Imipramine; Male; Mice; Motor Activity; Oxot | 1985 |
Interaction of oxotremorine with atropine, chlorpromazine, cyproheptadine, imipramine and phenoxybenzamine on the flexor reflex of the chronic spinal dog.
Topics: Animals; Atropine; Chlorpromazine; Cyproheptadine; Dogs; Drug Interactions; Imipramine; Oxotremorine | 1973 |
[On the clinical course and therapy of pathological conditions caused by incompatible antidepressants].
Topics: Adult; Anuria; Bipolar Disorder; Bis-Trimethylammonium Compounds; Depression; Depressive Disorder, M | 1968 |
Experimental evidence for imipramine like activity of fenfluramine.
Topics: Animals; Avoidance Learning; Blepharoptosis; Blood Pressure; Body Temperature; Cats; Columbidae; Dru | 1970 |
The adverse influence of imipramine on the adaptation of the newborn infant to extrauterine life.
Topics: Cyanosis; Depression; Female; Fetal Diseases; Fetus; Heart Failure; Humans; Imipramine; Infant, Newb | 1972 |
Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
Topics: Animals; Antidepressive Agents; Atropine; Behavior, Animal; Body Temperature; Cannabis; Dronabinol; | 1973 |
[Comparison of the effects of cholinergic and anticholinergic substances on the cerebral content of acetylcholine and on the motility of mice].
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Benactyzine; Brain Chemistry; Glycolates; Imipramine; | 1971 |
Arecoline and halothane shivering in thyroxine-treated mice.
Topics: Adjuvants, Anesthesia; Anesthesia, Inhalation; Animals; Body Temperature; Halothane; Hyperthyroidism | 1969 |
Blockade of norepinephrine uptake and related activities of cis- and trans-N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride.
Topics: Adipose Tissue; Amines; Animals; Atropine; Chlorpromazine; Cyclohexanes; Desipramine; Drug Antagonis | 1970 |
[The effect of desmethylimipramine and other "anti-tremorine" drugs on the metabolism of tremorine and oxotremorine in rats and mice].
Topics: Animals; Body Temperature; Brain; Desipramine; Drug Synergism; Imipramine; Liver; Male; Malonates; M | 1968 |
Evaluation of certain psychoanaleptic drugs as anti-parkinsonian agent: an experimental study.
Topics: Amitriptyline; Animals; Female; Imipramine; Male; Rats; Tremor | 1968 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |